STOCK TITAN

Zoetis to Participate in the Jefferies Virtual Pet Care Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Virtual Pet Care Summit on Thursday, Sept. 16, 2021. Glenn David, Executive Vice President and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance, will represent the company and respond to questions from analysts. He is scheduled to present at 11:00 a.m. ET.

Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After nearly 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide - from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. In 2020, Zoetis generated revenue of $6.7 billion with ~11,300 employees. For more, visit www.zoetis.com.

ZTS-COR
ZTS-IR

Media Contacts:

Bill Price

1-973-443-2742 (o)

william.price@zoetis.com



Kristen Seely

1-973-443-2777 (o)

kristen.seely@zoetis.com



Investor Contacts:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com



Keith Gaub

1-973-822-7154 (o)

keith.gaub@zoetis.com

Source: Zoetis Inc.

ZOETIS INC.

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Stock Data

72.76B
456.86M
0.23%
95.6%
0.8%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
PARSIPPANY

About ZTS

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.